Alaunos Therapeutics Inc. Revenue 2011–2025
Alaunos Therapeutics Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Alaunos Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Alaunos Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 2000, a 60.00% decrease year-over-year.
- Alaunos Therapeutics Inc. annual revenue for 2025 was 5000, a 50.00% decrease from 2024.
- Alaunos Therapeutics Inc. annual revenue for 2024 was 10000, a 100.00% increase from 2023.
- Alaunos Therapeutics Inc. annual revenue for 2023 was 5000, a 99.83% decrease from 2022.
- Alaunos Therapeutics Inc. annual revenue for 2022 was 2.9 M.
Alaunos Therapeutics Inc. (TCRT) — Frequently Asked Questions
Alaunos Therapeutics Inc. (TCRT) is a publicly traded US company. It has a market capitalization of $4M. In fiscal 2025 it reported revenue of $5,000 and net income of -$4M. Explore TCRT's stock price, financial statements, earnings history, margins and key ratios below.
What is Alaunos Therapeutics Inc.'s market cap?
Alaunos Therapeutics Inc. (TCRT) has a market capitalization of $4M.
What is the TCRT stock price?
TCRT trades at $1.97 (-1.01% on the day).
How much revenue does Alaunos Therapeutics Inc. make?
Alaunos Therapeutics Inc. reported revenue of $5,000 in fiscal 2025.
Is TCRT profitable?
In fiscal 2025, Alaunos Therapeutics Inc. reported net income of -$4M.